Thioridazine, Prolongatum
Thioridazine, Prolongatum Brand names, Thioridazine, Prolongatum Analogs
- Aldazine
- Mallorol
- Malloryl
- Meleril
- Mellaril
- Mellaril Hydrochloride
- Mellaril-S
- Mellarit
- Mellerets
- Mellerette
- Melleretten
- Melleril
- Metlaril
- Novoridazine
- Orsanil
- Ridazin
- Ridazine
- Sonapax
- Sonapax Hydrochloride
- Stalleril
- Thioridazin
- Thioridazine Chloride
- Thioridazine Hcl
- Thioridazine Hcl Intensol
- Thioridazine Hydrochloride
- Thioridazine Hydrochloride [Jan]
- Thioridazine, Prolongatum
- Thioridazinhydrochlorid
- Thoridazine Hydrochloride
- Tioridazin
- Usaf Sz-3
- Usaf Sz-B
Thioridazine, Prolongatum Brand Names Mixture
- No information avaliable
Thioridazine, Prolongatum Chemical_Formula
C21H26N2S2
Thioridazine, Prolongatum RX_link
http://www.rxlist.com/cgi/generic3/thioridazine.htm
Thioridazine, Prolongatum fda sheet
Thioridazine, Prolongatum msds (material safety sheet)
Thioridazine, Prolongatum Synthesis Reference
Bourquin et al., Helv. Chim. Acta 41, 1072 (1958)
Thioridazine, Prolongatum Molecular Weight
370.577 g/mol
Thioridazine, Prolongatum Melting Point
73 oC
Thioridazine, Prolongatum H2O Solubility
0.0336 mg/L
Thioridazine, Prolongatum State
Solid
Thioridazine, Prolongatum LogP
6.552
Thioridazine, Prolongatum Dosage Forms
Suspension; Tablet
Thioridazine, Prolongatum Indication
For the treatment of schizophrenia and generalized anxiety disorder.
Thioridazine, Prolongatum Pharmacology
Thioridazine is a trifluoro-methyl phenothiazine derivative intended for the management of schizophrenia and other psychotic disorders. Thioridazine has not been shown effective in the management of behaviorial complications in patients with mental retardation.
Thioridazine, Prolongatum Absorption
60%
Thioridazine, Prolongatum side effects and Toxicity
LD50=956-1034 mg/kg (Orally in rats); Agitation, blurred vision, coma, confusion, constipation, difficulty breathing, dilated or constricted pupils, diminished flow of urine, dry mouth, dry skin, excessively high or low body temperature, extremely low blood pressure, fluid in the lungs, heart abnormalities, inability to urinate, intestinal blockage, nasal congestion, restlessness, sedation, seizures, shock
Thioridazine, Prolongatum Patient Information
Thioridazine, Prolongatum Organisms Affected
Humans and other mammals
